PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30292747-8	2019	KM estimates of 2-year MFD-free survival for patients with gadolinium-enhanced lesions (GdE+) were 29% (95% CI, 11.7% to 48.2%) for untreated patients (n = 21).	Gadolinium	59-69	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	Homo sapiens	88-91